Genmab A (GMAB) Divestments (2018 - 2020)

Genmab A has reported Divestments for 3 years, with the latest figure at -$2565.0 in Q3 2020.

• For the quarter ending Q3 2020, Divestments rose 99.99% year-over-year to -$2565.0; the trailing twelve-month figure through Sep 2020 stood at -$460.6 million (changed N/A YoY), and the FY2019 full-year result was -$1983.0, up 100.0% from the prior year.
• Divestments for Q3 2020 stood at -$2565.0, down from -$46.0 in the prior quarter.
• The five-year high for Divestments was -$46.0 in Q4 2019, with the low at -$414.4 million in Q4 2018.
• Historically, Divestments has averaged -$115.2 million across 3 years, with a median of -$23.1 million in 2019.
• Annual changes were most pronounced in 2019 — Divestments soared 100.0% — and 2020, when it jumped 99.99%.
• Genmab A's Divestments stood at -$414.4 million in 2018, then soared by 100.0% to -$46.0 in 2019, then sank by 5476.09% to -$2565.0 in 2020.
• The last three Divestments figures came in at -$2565.0 (Q3 2020), -$46.0 (Q4 2019), and -$46.2 million (Q3 2019), per Business Quant data.